rs74658848

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001312909.2(FAM111A):​c.310T>A​(p.Leu104Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00176 in 1,614,162 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0094 ( 24 hom., cov: 33)
Exomes 𝑓: 0.00097 ( 23 hom. )

Consequence

FAM111A
NM_001312909.2 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.130

Publications

3 publications found
Variant links:
Genes affected
FAM111A (HGNC:24725): (FAM111 trypsin like peptidase A) The protein encoded by this gene is cell-cycle regulated, and has nuclear localization. The C-terminal half of the protein shares homology with trypsin-like peptidases and it contains a PCNA-interacting peptide (PIP) box, that is necessary for its co-localization with proliferating cell nuclear antigen (PCNA). Reduced expression of this gene resulted in DNA replication defects, consistent with the demonstrated role for this gene in Simian Virus 40 (SV40) viral replication. Mutations in this gene have been associated with Kenny-Caffey syndrome (KCS) type 2 and the more severe osteocraniostenosis (OCS, also known as Gracile Bone Dysplasia), both characterized by short stature, hypoparathyroidism, bone development abnormalities, and hypocalcemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
FAM111A-DT (HGNC:53752): (FAM111A divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026037097).
BP6
Variant 11-59151978-T-A is Benign according to our data. Variant chr11-59151978-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376886.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0094 (1432/152302) while in subpopulation AFR AF = 0.0328 (1363/41558). AF 95% confidence interval is 0.0313. There are 24 homozygotes in GnomAd4. There are 652 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1432 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM111ANM_001312909.2 linkc.310T>A p.Leu104Ile missense_variant Exon 6 of 6 ENST00000675163.1 NP_001299838.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM111AENST00000675163.1 linkc.310T>A p.Leu104Ile missense_variant Exon 6 of 6 NM_001312909.2 ENSP00000501952.1

Frequencies

GnomAD3 genomes
AF:
0.00935
AC:
1423
AN:
152184
Hom.:
24
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0327
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00242
AC:
608
AN:
251268
AF XY:
0.00164
show subpopulations
Gnomad AFR exome
AF:
0.0342
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000792
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000967
AC:
1413
AN:
1461860
Hom.:
23
Cov.:
31
AF XY:
0.000853
AC XY:
620
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0345
AC:
1155
AN:
33470
American (AMR)
AF:
0.00123
AC:
55
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000594
AC:
66
AN:
1112008
Other (OTH)
AF:
0.00210
AC:
127
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
83
165
248
330
413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00940
AC:
1432
AN:
152302
Hom.:
24
Cov.:
33
AF XY:
0.00876
AC XY:
652
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0328
AC:
1363
AN:
41558
American (AMR)
AF:
0.00327
AC:
50
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68024
Other (OTH)
AF:
0.00851
AC:
18
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
71
142
214
285
356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00145
Hom.:
1
Bravo
AF:
0.0105
ESP6500AA
AF:
0.0329
AC:
145
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00302
AC:
367
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 05, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 02, 2025
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
7.5
DANN
Benign
0.70
DEOGEN2
Benign
0.010
T;T;.;T;T;T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.59
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.65
.;T;T;.;.;.
MetaRNN
Benign
0.0026
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.2
M;M;.;M;M;M
PhyloP100
0.13
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.20
N;N;N;N;N;N
REVEL
Benign
0.051
Sift
Benign
0.38
T;T;T;T;T;T
Sift4G
Benign
0.85
T;T;T;T;T;T
Polyphen
0.91
P;P;.;P;P;P
Vest4
0.11
MVP
0.29
MPC
0.094
ClinPred
0.023
T
GERP RS
3.8
Varity_R
0.041
gMVP
0.14
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74658848; hg19: chr11-58919451; API